Dr. Lifschitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Shaare Zedek Medical Center
Jerusalem, Israel
FPO, AP 96427
Education & Training
- University of California (San Francisco)Residency, Internal Medicine, 1971 - 1973
- University of California (San Diego) Medical CenterInternship, Internal Medicine, 1970 - 1971
- University of Pennsylvania Health SystemInternship, Internal Medicine, 1967 - 1968
- Boston University School of MedicineClass of 1967
- Boston UniversityMA, Physiology, 1966
- Massachusetts Institute of TechnologyBS, 1963
Certifications & Licensure
- TX State Medical License 2004 - 2028
- DC State Medical License 2007 - 2013
Awards, Honors, & Recognition
- Alpha Omega Alpha Begg Society, 1966
- Whos Who in Medicine and Healthcare Marquis Whos Who
Publications & Presentations
PubMed
- 18 citationsB2-Microglobulin and Associated Amyloidosis Presenting as Bilateral Popliteal TumorsWoody Reese, Aviva Hopkovitz, Meyer D. Lifschitz
American Journal of Kidney Diseases. 1988-10-01 - 39 citationsGastrointestinal Blood Loss in Patients With Chronic Renal FailureSteven G. Rosenblatt, Samuel T. Drake, Steven Fadem, Richard Welch, Meyer D. Lifschitz
American Journal of Kidney Diseases. 1982-01-01 - 72 citationsAldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigmsLinda Shavit, Meyer D. Lifschitz, Murray Epstein
Kidney International. 2012-05-02
Journal Articles
- Preoperative Renal Dysfunction and Anemia Predict outcomes after cardiac surgeryLinda Shavit, Meyer Lifschitz, Rachel Tauber, Daniel Bitran and Daniel Fink, CJASN, 7/1/2014
- Long-term Hypoparathyroidism and Hypophosphatemia in a Dialysis PatientL Shavit, M Lifschitz and I Slotki, Journal of Investigative Medicine High Impact Case Reports, 5/1/2014
- Pegylated liposomal do:xorubicin and renal thrombotic microangiopathy: an under recognized complication of prolonged treatmentL Shavit, M Lifschitz et al, Kidney Inter, 1/1/2014
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: